Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

FINAL TERMS: Phoenix Pharma E500m 5NCL sr notes at 5% yield

HYC European Market: Deal Flow - General

PHOENIX PIB Dutch Finance BV (PHARGR) EUR500m (from EUR400-500m) Reg S sr unsec notes due 07/10/29 (5y). NCL (MWC) (3m par call) (85% clean-up call). NR/BB+ (--/stable). Via Barc/BofA/DB (B&D)/ING/LBBW/SEB jt glocos and books. List Lux. German law. CoC. Settles 07/10. ISIN: XS2856820704. IPT: 5.375%-5.50%. Guidance: 5.125% area (+/- 0.125%).

Final terms: EUR500 at 5.00% yield.

Investor calls started 07/01. Books closed at 1pm UKT 07/03. Pricing 07/03 UK afternoon. Books over EUR2bn (pre-rec). UOP: GCP, repayment of existing debt, including the tender offer for its EUR400m 2.375% fixed rate bearer notes due 08/05/25 (ISIN: XS2212959352), repurchase price 98.35, expires 5pm CEST 07/09/24, Barc/BofA/DB/ING/LBBW/SEB dealer managers. Biz: a leading integrated healthcare provider in Europe operating in Pharmaceutical Wholesale, Pharmaceutical Retail and Pharma Services. HQ: Marassen, The Netherlands/Mannheim, Germany.

Investor Presentation:http://www.netroadshow.com/nrs/home/#!/?show=929acbfe| Entry Code: Adelphi2024 (not case-sensitive)

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.